Kymera Therapeutics Inc (KYMR)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -97.068 | -51.259 | -18.097 | -18.337 | -25.608 | -24.932 |
Return on Equity (%) | 124.678 | 75.791 | -52.17 | -26.957 | -32.598 | -33.207 |
Return on Invested Capital (%) | -109.48 | -115.232 | -59.977 | -44.9 | -49.061 | -50.403 |
Operating Margin (%) | N/A | -1404.226 | -133.625 | -137.36 | -330.227 | -186.744 |
Net Profit Margin (%) | N/A | -1405.794 | -160.554 | -137.6 | -330.603 | -186.994 |
Book Value Per Share | 16.529 | 11.269 | 6.335 | 8.919 | 8.906 | 7.118 |
Earnings Per Share | -9.1 | -13.405 | -1.219 | -1.945 | -2.813 | -2.649 |
Cash Per Share | 17.49 | 24.704 | 0.692 | 0.931 | 1.243 | 1.982 |
Working Capital Per Share | 15.728 | 18.939 | 4.278 | 6.961 | 6.324 | 5.76 |
Operating Profit Per Share | N/A | 0.954 | 0.76 | 1.413 | 0.851 | 1.416 |
EBIT Per Share | -9.1 | -13.405 | -1.017 | -1.945 | -2.813 | -2.649 |
EBITDA Per Share | -9.1 | -13.405 | -1.017 | -1.945 | -2.813 | -2.649 |
Free Cash Flow Per Share | -8.612 | -13.5 | -1.056 | -1.96 | -2.815 | -2.091 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,36M | 3,08M | 44,81M | 51,54M | 55,04M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 55,04M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -431.787 | N/A | N/A | N/A | -471.352 | N/A | N/A |
Net Profit Margin (%) | N/A | -432.368 | N/A | N/A | N/A | -472.023 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,65B |
Ratio cours/bénéfice | -18,36 |
Ratio prix/ventes | 34,34 |
Ratio prix/liquidités | 24,54 |
Ratio prix/valeur comptable | 6,83 |
Rendement de dividende | - |
Actions en circulation | 64,77M |
Volume moyen (1 semaine) | 433,37k |
Volume moyen (1 mois) | 479,74k |
Variation sur 52 semaines | 76,98% |
Plus haut sur 52 semaines | 53,27 |
Plus bas sur 52 semaines | 22,35 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales